НовостиBenzingaRBC Capital Reiterates Sector Perform on Aardvark Therapeutics, Maintains $6 Price Target RBC Capital Reiterates Sector Perform on Aardvark Therapeutics, Maintains $6 Price Target Benzinga 2026.09.24 13:27 (GMT+0) Открыть на Benzinga Другие новости